These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 9015113
1. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Arch Virol Suppl; 1996; 12():163-75. PubMed ID: 9015113 [Abstract] [Full Text] [Related]
3. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children. Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML. Rev Infect Dis; 1989; 11 Suppl 3():S539-46. PubMed ID: 2548276 [Abstract] [Full Text] [Related]
4. Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK. Hoshino Y, Jones RW, Chanock RM, Kapikian AZ. Vaccine; 2002 Oct 04; 20(29-30):3576-84. PubMed ID: 12297404 [Abstract] [Full Text] [Related]
6. A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: development, utilization and withdrawal. Kapikian AZ. Novartis Found Symp; 2001 Oct 04; 238():153-71; discussion 171-9. PubMed ID: 11444025 [Abstract] [Full Text] [Related]
7. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Vesikari T, Ruuska T, Green KY, Flores J, Kapikian AZ. Pediatr Infect Dis J; 1992 Jul 04; 11(7):535-42. PubMed ID: 1326741 [Abstract] [Full Text] [Related]
8. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups. Madore HP, Christy C, Pichichero M, Long C, Pincus P, Vosefsky D, Kapikian AZ, Dolin R. J Infect Dis; 1992 Aug 04; 166(2):235-43. PubMed ID: 1321858 [Abstract] [Full Text] [Related]
11. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru. Lanata CF, Black RE, Flores J, Lazo F, Butron B, Linares A, Huapaya A, Ventura G, Gil A, Kapikian AZ. Vaccine; 1996 Feb 04; 14(3):237-43. PubMed ID: 8920706 [Abstract] [Full Text] [Related]
12. Rotavirus vaccines and vaccination in Latin America. Linhares AC, Bresee JS. Rev Panam Salud Publica; 2000 Nov 04; 8(5):305-31. PubMed ID: 11190969 [Abstract] [Full Text] [Related]
13. Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity. Hoshino Y, Jones RW, Chanock RM, Kapikian AZ. J Med Virol; 1997 Apr 04; 51(4):319-25. PubMed ID: 9093947 [Abstract] [Full Text] [Related]
14. Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines. Hoshino Y, Jones RW, Ross J, Kapikian AZ. Vaccine; 2003 Jun 20; 21(21-22):3003-10. PubMed ID: 12798644 [Abstract] [Full Text] [Related]
19. [Rotaviruses in human and veterinary medicine]. Dodet B, Heseltine E, Mary C, Saliou P. Sante; 1997 Jun 20; 7(3):195-9. PubMed ID: 9296811 [Abstract] [Full Text] [Related]
20. Clinical and immunological studies of rotavirus vaccines. Vesikari T. Southeast Asian J Trop Med Public Health; 1988 Sep 20; 19(3):437-47. PubMed ID: 2851185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]